27 & 28 October 2020
Save The Date !
With the Covid pandemic19 , we are witnessing at first hand the ease with which any object or person can be contaminated or infected and are aware of the importance of putting in place the appropriate means to prevent or reduce the risk of transmission. In the context of aseptic manufacturing, “Barrier Technologies” are the means that help us guarantee the safety and integrity of the product, environment and/or personnel.
In recent years, barrier technologies have evolved enormously and what were once considered expensive or sophisticated systems, such as isolators, are now essential to ensure the required quality levels. In this sense, the pharmaceutical industry in our country has to make an effort to update its facilities and processes.
In this webinar, the expert speakers will present the current state of technical advances, and the experiences and lessons learned in multiple projects related to containment and aseptic manufacturing.
In addition, A3P has been one of the associations selected to receive industry comments on Annex 1.
During this webinar the Working Group of Interest “A3P Annex 1” will present the evolution of Chapter 4 and the final version of the comments sent to the EMA explaining the process of reflection, the objective and the analysis of the associated risks.
Oficial language : English
Please note that the programme may be subject to change.
Tuesday 27 October 2020
Wednesday 28 October 2020
Depending on your requirements and preferences, you can contact Florian Canuto:
Phone number: +33 (0)7 61 55 24 36
Fax : +33 (0)4 37 28 30 60
Email : email@example.com
Courrier : A3P, 30 rue Pré-Gaudry – Lyon 69007